These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 3284035)
1. Intraperitoneal nucleopore chambers: a murine model for allograft rejection. Lum CT; Hannapel CE; Wanner FJ; Tio FO; Kung JT Transplant Proc; 1988 Apr; 20(2):173-5. PubMed ID: 3284035 [No Abstract] [Full Text] [Related]
2. In vitro and in vivo human T cell repertoire in kidney allograft rejection. Finn OJ; Miceli MC; Sanfilippo A; Bollinger RR; Barry TS Transplant Proc; 1988 Apr; 20(2):155-8. PubMed ID: 3284032 [No Abstract] [Full Text] [Related]
3. Enhanced expression of a novel cytotoxicity-linked serine esterase by T lymphocytes during allograft rejection. Sunder-Plassmann G; Wagner L; Stockenhuber F; Balcke P; Worman CP Transplant Proc; 1989 Feb; 21(1 Pt 1):301. PubMed ID: 2650127 [No Abstract] [Full Text] [Related]
4. Effector T-cell repertoire selection in human allograft rejection. Finn OJ; Miceli MC Transplant Proc; 1989 Feb; 21(1 Pt 1):346-8. PubMed ID: 2495608 [No Abstract] [Full Text] [Related]
5. Human renal allograft infiltrating T cells: phenotype-function correlation and clonal heterogeneity. Miceli MC; Barry TS; Finn OJ Transplant Proc; 1988 Apr; 20(2):199-201. PubMed ID: 3284040 [No Abstract] [Full Text] [Related]
6. ICOS/B7RP-1 interference in mouse kidney transplantation. Lutz J; Lu R; Strobl M; Huang H; Deng M; Wang M; Ouyang N; Heemann U Transplantation; 2007 Jul; 84(2):223-30. PubMed ID: 17667814 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells. Nanishi F; Nomoto K; Taniguchi K; Kubo C Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243 [TBL] [Abstract][Full Text] [Related]
8. Construction of rat-mouse T hybridoma clones from rat kidney allograft-infiltrating cells with helper activity. Manca F; Haalttunen J; Ferry B; Jaakkola M; Gessaga M; Häyry P Transplant Proc; 1988 Apr; 20(2):159-60. PubMed ID: 2966465 [No Abstract] [Full Text] [Related]
9. Large agranular lymphocytes: early non-specific effector cells in allograft rejection in the mouse. Gregory CD; Atkinson ME Immunology; 1984 Oct; 53(2):257-65. PubMed ID: 6386672 [TBL] [Abstract][Full Text] [Related]
10. Analysis of infiltrating lymphocytes from fine needle aspiration biopsies in kidney transplant patients by a rapid and sensitive immunomagnetic method. Pfeffer PF; Gjertsen HA; Gaudernack G; Lexow PB; Sodal G; Thorsby E Transplant Proc; 1989 Feb; 21(1 Pt 1):354-5. PubMed ID: 2495609 [No Abstract] [Full Text] [Related]
11. Rapid immunodiagnosis of kidney rejection by using activation markers on kidney tubular cells and infiltrating T subset cells. Tötterman TH; Hanås E; Larsson E; Lindgren PG; Sjöberg O; Wahlberg J; Tufveson G Transplant Proc; 1987 Oct; 19(5):3570-1. PubMed ID: 3313860 [No Abstract] [Full Text] [Related]
12. Characterization of kidney-specific peptides and their role in renal allograft rejection. Poindexter NJ; Naziruddin B; Oppat W; Flye MW; Mohanakumar T Transplant Proc; 1995 Feb; 27(1):900-2. PubMed ID: 7879223 [No Abstract] [Full Text] [Related]
13. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection. Campos HH; Bach JF; Chatenoud L Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486 [No Abstract] [Full Text] [Related]
14. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model. Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884 [TBL] [Abstract][Full Text] [Related]
15. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients. Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808 [TBL] [Abstract][Full Text] [Related]
16. Relationships among renal allograft biopsy infiltrates, growth of T cell lines, and irreversible rejection. Kolbeck PC; Miceli C; Finn OJ; Bollinger RR; Sanfilippo F Transplant Proc; 1988 Apr; 20(2):303-5. PubMed ID: 3284060 [No Abstract] [Full Text] [Related]
17. Cytotoxicity and IL 2 reactivity of cells from rejected or nonrejected allografts. Dallman MJ; Wood KJ; Morris PJ Transplant Proc; 1988 Apr; 20(2):226-8. PubMed ID: 3129832 [No Abstract] [Full Text] [Related]
18. Reflections on use of the renal biopsy as the "gold standard" in distinguishing transplant rejection from cyclosporine nephrotoxicity. Solez K; McGraw DJ; Beschorner WE; Kone BC; Racusen LC; Whelton A; Burdick JF Transplant Proc; 1985 Aug; 17(4 Suppl 1):123-33. PubMed ID: 3927535 [No Abstract] [Full Text] [Related]
19. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection. Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the mechanism of allograft rejection and cell-mediated immunity. II. Divergent effect of CY pretreatment on the generation of cytotoxic activity in the draining lymph nodes and spleen. Nanishi F; Taniguchi K; Kubo C; Onoyama K; Omae T; Nomoto K J Clin Lab Immunol; 1983 Sep; 12(1):23-30. PubMed ID: 6631941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]